Face it fellow investors. A marketing distribution agreement with a single foreign sovereign rep. is not going to move stock price, Investor confidence has been eroded too much for too long. There are only three things that will move Generex: Lsiting of NGIO and Uplist of GNBT, IND approval, or a big pharma or financial partner buy-in. No more talk of future expectations, intentions, initiatives or completion of interim procedural hurdles are going to matter. Probably treading more water in offing but things could deteriorate further.
Generex Biotechnology Corp. (GNBT) Stock Research Links